Caisse Des Depots ET Consignations Lowers Stock Holdings in Alignment Healthcare, Inc. $ALHC

Caisse Des Depots ET Consignations lowered its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 48.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 82,053 shares of the company’s stock after selling 77,131 shares during the period. Caisse Des Depots ET Consignations’ holdings in Alignment Healthcare were worth $1,432,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Teacher Retirement System of Texas lifted its position in Alignment Healthcare by 85.8% during the third quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock valued at $1,794,000 after purchasing an additional 47,472 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of Alignment Healthcare during the 3rd quarter valued at $3,499,000. Inspire Investing LLC bought a new stake in shares of Alignment Healthcare during the 3rd quarter worth $1,129,000. Ameritas Investment Partners Inc. grew its position in Alignment Healthcare by 32.9% in the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after acquiring an additional 3,225 shares in the last quarter. Finally, Schroder Investment Management Group grew its position in Alignment Healthcare by 28.7% in the second quarter. Schroder Investment Management Group now owns 248,163 shares of the company’s stock worth $3,437,000 after acquiring an additional 55,314 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Stock Performance

Shares of NASDAQ:ALHC opened at $20.39 on Thursday. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The company has a 50-day moving average price of $20.88 and a 200-day moving average price of $17.98. The company has a market cap of $4.08 billion, a price-to-earnings ratio of -169.92, a price-to-earnings-growth ratio of 5.26 and a beta of 1.16. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 180,000 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $20.49, for a total value of $3,688,200.00. Following the completion of the transaction, the chief executive officer directly owned 2,652,641 shares in the company, valued at approximately $54,352,614.09. This represents a 6.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Hyong Kim sold 16,506 shares of the firm’s stock in a transaction dated Tuesday, January 6th. The stock was sold at an average price of $21.35, for a total transaction of $352,403.10. Following the completion of the sale, the insider directly owned 333,133 shares of the company’s stock, valued at approximately $7,112,389.55. This represents a 4.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 2,120,938 shares of company stock worth $41,655,670. Corporate insiders own 7.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on ALHC shares. UBS Group upped their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, January 14th. JPMorgan Chase & Co. increased their price target on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Barclays upped their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, October 31st. Piper Sandler lifted their target price on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 6th. Finally, TD Cowen upped their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research report on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Alignment Healthcare has an average rating of “Moderate Buy” and an average target price of $23.32.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.